ResearchMoz

Computer-aided Design Market in Australia 2011-2015

Technavio
Published Date » 2012-09-21
No. Of Pages » 36
   
TechNavio's analysts forecast the Computer-aided Design market in Australia to grow at a CAGR of 8.5 percent over the period 2011-2015. One of the key factors contributing to this market growth is the need to enhance the quality of the product. The Computer-aided Design market in Australia has also been witnessing the increasing demand of 3D CAD software. However, the availability of pirated CAD software could pose a challenge to the growth of this market.   TechNavio's research report, the Computer-aided Design Market in Australia 2011-2015, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Computer-aided Design market landscape and its growth prospects in the coming years. The report also includes a discussion of the...
Table of Content

1. Executive Summary

2. Introduction

3. Market Coverage
Market Overview
Key Offerings

4. Market Landscape
4.1 Market Size and Forecast
4.2 End-User Segmentation
4.3 Five Forces Analysis

5. Vendor Landscape

6. Buying Criteria

7. Market Growth Drivers

8. Drivers and their Impact

9. Market Challenges

10. Impact of Drivers and Challenges

11. Market Trends

12. Key Vendor Analysis
12.1 Autodesk Inc.
Business Overview
SWOT Analysis
12.2 Dassault Systmes SA
Business Overview
SWOT Analysis
12.3 Parametric Technology Corp.
Business Overview
SWOT Analysis
12.4 Siemens PLM Software Inc.
Business Overview
SWOT Analysis

13. Other Reports in this Series

List of Tables


Exhibit 1: CAD Market in Australia 2011-2015 (US$ million)
Exhibit 2: Comparison of 2D and 3D CAD Market in Australia 2011-2015
Exhibit 3: Comparison of CAD Market in Australia with Global Computer-aided Design Market 2011 (percentage)
Exhibit 4: CAD Market in Australia by End-user Segmentation 2011
Exhibit 5: CAD Market in Australia by Vendor Segmentation 2011

List of Figures

NA

Upcoming Reports:

Biosimulation Market - Global Scenario, Trends, Industry Analysis, Size, Share And Forecast, 2011 - 2018
By - Transparency Market Research
Biosimulation is computer aided mathematical simulation of biological systems and processes. Biosimulation is used for model based calculation of biological systems. The global biosimulation market is expected to grow at a considerable rate from 2011 to 2018.The primary reason for the growth of biosimulation is the increasing use of pharmacodynamic and pharmacokinetic (PKPD) modeling in pre-clinical drug development. PKPD is the most widely used method in drug development.  Increasing importance of advanced techniques to reduce the drug development and discovery cost is the...
Lyophilization for Pharmaceuticals Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019
By - Transparency Market Research
Lyophilization also called as freeze drying is a process of dehydration of samples, commonly used to preserve perishable substances. In pharmaceutical industries, it is used to concentrate and stabilize products into powder form. The process consists of four stages- lyophilization pretreatment, freezing the compound, primary drying process, secondary drying. Pretreating the products includes concentrating the product and formulation to increase the surface area. Once the product is pretreated, it is frozen using methanol or liquid nitrogen. At this stage, the compound is cooled below...
Metal And Ceramic Injection Molding Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019
By - Transparency Market Research
Metal injection molding (MIM) and ceramic injection molding (CIM) are advanced net shape processing technologies used for the manufacture of complex, high-volume components. Together, these molding technologies are known as powder injection molding (PIM). The technology is gaining importance as new components are being designed that require high mechanical strength while being small in size. Additionally, industries such as automotive and aerospace are looking at reducing production costs, which can be achieved using metal and ceramic injection molding processes. The low cost complex...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Order cancellations not a sign of market slump: Airbus
Jul 31, 2014  
Leading aircraft manufacturer Airbus on Wednesday said that the recent wave of order cancellations for its commercial jetliners do not mean that the market has declined. The market is still strong and single-aisle jets deals are likely to return later. A total of 225 Airbus cancellations were reported since the beginning of this year. Of these, Dubai’s Emirates Airlines alone...
Leading Australian Universities Want to Hike Fees, Enroll Fewer Students
Jul 31, 2014  
Australia’s prestigious group of top eight universities, also known as the Group of Eight (Go8), has indicated plans of increasing tuition fees while reducing the number of students they enroll, a reform-backer has predicted. These decisions could be made if the universities are deregulated .  Arguing for this decision, the chairman of Go8, and vice chancellor of the ANU, Ian...
Bristol-Myers Squibb Posts USD 3.9 billion Revenues in 2014 Second Quarter
Jul 30, 2014  
Leading bio-pharmaceutical company Bristol-Myers Squibb has registered revenues of USD 3.9 billion in the 2014 second quarter. This marks a 4% decrease from the same period in 2013. The global revenues of the company (excluding the divested Diabetes Alliance), saw a 7% increase. In this quarter, the company’s results were underlined by steady global sales of nearly each of its...
Novartiss Simbrinza gets approval from the EU
Jul 30, 2014  
Glaucoma patients in Europe can easily obtain Novartis’ Simbrinza eye drops which are a combination of brimonidine tartrate and brinzolamide and it is without a beta-blocker. This eye drop has got the approval of the European Commission. Unlike the inefficient treatment provided by monotherapy, this eye drop aims at treating intraocular pressure or IOP in adults with ocular hypertension...
Second Treaty Between Zealand And Boehringer Ingelheim
Jul 30, 2014  
Denmark based Pharma group Zealand Pharma and Germany’s Boehringer Ingelheim have signed an accord to formulate new medicines for advanced and effective treatment of cardio-metabolic maladies. The collaboration between these two Pharma groups involves a new therapeutic peptide project from the list of preclinical programs of Zealand Pharma.  Both these companies are aiming...